ObamaCare created a Medicaid time bomb By Michael D.

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
ObamaCare created a Medicaid time bomb

By Michael D. Tanner
December 7, 2013 | 9:15pm

The good news, if you want to call it that, is that roughly 1.6 million Americans have enrolled in ObamaCare so far.

The not-so-good news is that 1.46 million of them actually signed up for Medicaid. If that trend continues, it could bankrupt both federal and state governments.

Medicaid is already America’s third-largest government program, trailing only Social Security and Medicare, as a proportion of the federal budget. Almost 8 cents out of every dollar that the federal government spends goes to Medicaid. That’s more than $265 billion per year.

Indeed, already Social Security, Medicare and Medicaid account for 48% of federal spending. Within the next few years, those three programs will eat up more than half of federal expenditures.

And it’s going to get worse. Congress has shown no ability to reform Social Security or Medicare. With ObamaCare adding to Medicare spending, we are picking up speed on the road to insolvency.

The Congressional Budget Office projects that, in part because of ObamaCare, Medicaid spending will more than double over the next 10 years, topping $554 billion by 2023.

And that is just federal spending.

State governments pay another $160 billion for Medicaid today. For most states, Medicaid is the single-largest cost of government, crowding out education, transportation and everything else.

New York spent more than $15 billion on Medicaid last year, roughly 30% of all state expenditures. The Kaiser Foundation projects that over the next 10 years, New York taxpayers will shell out some $433 billion for the program.

But none of these projections foresaw that so many of ObamaCare’s enrollees would be Medicaid eligible.

To be sure, the health-care law’s designers saw the expansion of Medicaid as an important feature of their plan to expand coverage for the uninsured. Still, they expected most of those enrolling in ObamaCare to qualify for private (albeit subsidized) insurance.

It’s beginning to look like that was just another miscalculation, one that could have very serious consequences for the program’s costs. (bolded for emphasis)

Moreover, any projection of Medicaid’s future cost to New York taxpayers assumes that the federal government keeps its promise to pay 100% of the cost for Medicaid’s expansion over the next three years and 90% thereafter. But given the growing burden that Medicare will put on a federal budget already facing high debt levels, how likely is it that changes in the federal share of Medicaid will stay off the table?

In fact, as part if last December’s fiscal-cliff negotiations, the Obama administration briefly considered changing to a “blended” reimbursement rate, somewhere between the current and promised rates. The administration quickly backed away from the offer, but it’s likely to come back in the future. If it does, it would cost New York tens of millions of dollars.

Every bit as bad as the cost is the fact that for all this money, recipients are going to get pretty lousy health care. (bolded for emphasis)

Of course, one might say that even bad health care is better than no health care. But, unfortunately, for Medicaid, that’s not true.

The Oregon Health Insurance Exchange study, the first randomized controlled study of Medicaid outcomes, recently concluded that, while Medicaid increased medical spending increased from $3,300 to $4,400 per person, “Medicaid coverage generated no significant improvements in measured physical-health outcomes.”

Other studies show that, in some cases, Medicaid patients actually wait longer and receive worse care than the uninsured.

While Medicaid costs taxpayers a lot of money, it pays doctors very little. On average, Medicaid only reimburses doctors 72 cents out of each dollar of costs. ObamaCare does attempt to address this by temporarily increasing Medicaid reimbursements for primary-care doctors, but that increase expires at the end of next year.

Because of the low reimbursement, and the red tape that accompanies any government program, many doctors limit the number of Medicaid patients they serve, or even refuse to take Medicaid patients at all. An analysis published in Health Affairs found that only 69% of physicians accept Medicaid patients. A study published in the New England Journal of Medicine found that individuals posing as mothers of children with serious medical conditions were denied an appointment 66% of the time if they said that their child was on Medicaid (or the related CHIP), compared with 11% for private insurance — a ratio of 6 to 1.

Even when doctors do still treat Medicaid patients, they often have a harder time getting appointments and face longer wait times. One study found that among clinics that accepted both privately insured children and those enrolled in Medicaid, the average wait time for an appointment was 42 days for Medicaid compared to just 20 days for the privately insured. One study found that among clinics that accepted both privately insured children and those enrolled in Medicaid, the average wait time for an appointment was 42 days for Medicaid compared to just 20 days for the privately insured.

That’s one reason why so many Medicaid patients show up at the emergency room for treatment. They can’t find a doctor to treat them otherwise.

This not only increases the strain on already overburdened emergency room doctors, but increases the wait for those who arrive with real emergencies.

As bad as this is now, ObamaCare will make it worse by increasing the number of people on Medicaid without doing anything to increase the number of doctors treating them.

We don’t know yet whether the rush to Medicaid will continue. It may be that the troubles with the ObamaCare website might have skewed the early signups. But if ObamaCare really does lead to a massive expansion of this costly and inefficient program, that’s bad news for taxpayers, providers and patients.

Michael D. Tanner is a senior fellow at the Cato Institute.

http://nypost.com/2013/12/07/the-medicaid-time-bomb/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MAMMOTION's Bold Leap in Robotic Lawn Care at IFA 2026

Updated Category News Views 3

MAMMOTION Makes Waves with New Robotic Mowers Gather 'round, folks, because MAMMOTION's making some noise over at IFA 2026 in Berlin. If you've been stuck battling the wild edges of your lawn with a rusty old mower, MAMMOTION might just have the tech to save your weekends—and some grass along the way. This ain't no shiny gadget; it’s a full-on upgrade to lawn war...

Continue Reading
Holland America Evolution: Revamping Luxury at Sea

Updated Category News Views 3

Setting Sail on a Fresh Wave of Luxury It's a whole new world aboard the Oosterdam, folks. Holland America's making waves with the debut of a reimagined Ocean Bar that promises to inject a healthy dose of glamour back into cruising. Forget the stuffy maritime tales of yesteryear; this isn't just a facelift—it's a full-blown Renaissance at sea. A nod to the golden age of...

Continue Reading
Beyoncé Drops Remastered 'B'DAY'; Celebrates Legacy

Updated Category News Views 2

Every so often, an artist comes around who's not just making music but shifting the very landscape of their genre. Beyoncé isn't just marking her birthday today; she's reminding the world of a career-defining moment with the release of her remastered deluxe version of 'B'DAY'. This isn't just a stroll down memory lane; it's a full-blown revival of an era that reshaped...

Continue Reading
Eosera Defies Odds with Texas-Made Ear Care Dominance

Updated Category News Views 3

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

Continue Reading
Aardvark Therapeutics Faces Investor Lawsuit for Fraud

Updated Category News Views 1

Investors' Trust on Shaky Grounds There it is, staring right back at investors: a securities fraud class action lawsuit against Aardvark Therapeutics. Not exactly the news a shareholder wants to digest over breakfast. If you’ve got skin in the game with Aardvark Therapeutics (NASDAQ: AARD), you might wanna keep reading. Hagens Berman Sobol Shapiro LLP, a name that's no...

Continue Reading
Hamamatsu & AIxMed to Automate Cytology Workflows

Updated Category News Views 2

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Continue Reading
Aristocrat's Tiki Fire Slots Heat Up North America

Updated Category News Views 0

The Polynesian Flame Ignites: Tiki Fire Hits Online Games Just when you thought the iGaming world was catching its breath, Aristocrat Interactive throws another curveball. The buzz around their Lightning Link™ series, especially the launch of High Stakes™ in July, took the scene by storm. Now, just in time for another sizzle, they've rolled out Tiki Fire™, bringing...

Continue Reading
USSM and IonicRE Partner to Enhance US Rare Earths Supply

Updated Category News Views 1

Sometimes, it's not just about playing the game, but knowing which card to play. US Strategic Metals (USSM) and Ionic Rare Earths USA just unveiled a strategic move that’s likely to shake things up in the wild world of rare earths. As the partnership gears up to build a magnet recycling facility in Missouri, there’s chatter around creating a sustainable supply chain...

Continue Reading
Wise Group Investors Alert Ahead of Key Legal Deadline

Updated Category News Views 0

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Continue Reading
Curaleaf Eyes Growth: Conference Signals Opportunities

Updated Category News Views 1

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Continue Reading

Top 5 Most Recently Viewed Articles

Beazer Homes Boosts Share Repurchase Campaign Amid Market Changes

Updated Category News Views 95

Beazer Homes Increases Share Repurchase Initiative Beazer Homes USA, Inc. (NYSE: BZH) has recently communicated a significant acceleration in its share repurchase activity, a move prompted by fluctuations in its share price. The company has approximately $24.8 million remaining under its authorized share repurchase program. This decision illustrates Beazer's commitment to...

Continue Reading
Takeda Shares Groundbreaking Findings on Narcolepsy Treatment

Updated Category News Views 94

Groundbreaking Narcolepsy Treatment Insights by Takeda In a major development for those living with narcolepsy, Takeda will share important findings about its innovative drug, TAK-861, at Sleep Europe 2024. This conference is a key moment for Takeda to highlight progress in both understanding and treating this complex condition. Narcolepsy typically presents as...

Continue Reading
Celebrate Presidents Day with the U.S. Postal Service Updates

Updated Category News Views 151

Understanding Presidents Day Observance by the U.S. Postal Service The U.S. Postal Service (USPS) recognizes Presidents Day as a holiday, meaning that all Post Office locations will be closed, providing a day of rest for employees while encouraging customers to utilize self-service options. This aligns with the USPS commitment to serving communities effectively. Accessing...

Continue Reading
Sidetrade Celebrates Major Milestone in Euronext Tech Leaders

Updated Category News Views 180

Sidetrade's Prominent Inclusion in Euronext's Tech Leaders Sidetrade, a frontrunner in AI-driven Order-to-Cash applications, recently announced its inclusion in the prestigious Euronext Tech Leaders Index, a pan-European initiative that highlights the continent’s most innovative and rapidly growing tech companies. This initiative, launched in 2022 by Euronext,...

Continue Reading
Cue Biopharma Sees Promising Growth in Recent Financial Review

Updated Category News Views 125

Cue Biopharma's Financial Highlights and Strategic Changes BOSTON — Cue Biopharma, Inc. (NASDAQ: CUE), a trailblazer in the biopharmaceutical sector, is focused on revolutionizing immunotherapy through its innovative therapies. The company has reported substantial progress in its fourth quarter and full year 2024 financial results, underscoring its commitment to...

Continue Reading